Top

Global Sexually Transmitted Diseases (STDs) Testing Market (Disease Types, Testing Volume, Testing Devices and Geography)

Industry Analysis and Forecast, 2013 - 2020
Category : Medical Devices  | Published Date : Nov-2014
enquire Customize Report GET DISCOUNT

Sexually Transmitted Diseases (STDs) are also known as Venereal diseases (VDs) or Sexually Transmitted Infections (STIs). A variety of methods have been employed for diagnosis of STDs that differ based on the type of disease. The objective of this report is to provide an in-depth understanding of diagnostic tests of STDs. The market diagnostic testing of STDs was valued at $96.7 billion in 2013 with a corresponding test volume of 4,204 million. Rising incidences of fatal STDs, corresponding high-economic burden and consequent implementation of Provider-Initiated Counselling and Testing (PICT) and Client-Initiated Counselling and Testing (CICT) drive the growth of STD testing market; however, inadequate infrastructure provisions such as labs, equipment and supplies, lack of trained laboratory personnel in the secluded geographic locations (for example, West African countries) and stigma associated with voluntary testing are likely to be the major restraints of the market. However, global initiatives along with development in healthcare infrastructure will provide future growth thrust for the market. Thus, the diagnostic testing of STDs is estimated to grow at a CAGR of 8.5% over the forecast period 2014-2020 to reach market size of $167.4 billion in 2020. The test volume will rise to 5,520 million in 2020.

The global market for diagnostic testing of STDs is segmented based on types of STDs – Chlamydia testing, Gonorrhoea testing, Syphilis testing, Human Immunodeficiency Virus (HIV) testing, Herpes Simplex Virus (HSV) testing, Human Papilloma Virus (HPV) testing and Chancroid testing. HIV testing, which is the third largest STD testing market, would grow at a CAGR of 10.9% during 2014 – 2020.

Based on point of testing, market is segmented in to laboratories and point-of-care (PoC). Currently, laboratories perform bulk of the tests and would continue to hold larger share of the market, both in terms of volume and revenue. PoCs will grow at constant rate during the forecast period.

The report also provides market size and forecast for testing devices used for carrying such tests. The market for STD testing devices was valued at $7.7 billion in 2013 with laboratory testing devices accounted for the most of the market and PoC devices shall grow at fastest rate.

As elaborated earlier, many healthcare institutions provide diagnostic testing services for STDs, such as specialized STD clinics, Genito-Urinary Medicine (GUM) clinics along with general hospitals, government laboratories and private diagnostic centres. The afore-mentioned thus constitute key market participants of the global diagnostic testing of STDs market. Along with the testing service providers, many companies provide devices such as laboratory instruments and POC testing kits/devices for STDs; for instance, Roche Holdings AG. Roche Holdings AG recently announced an immunoassay diagnostic test for the detection of Syphilis during a routine clinical practice. Other companies profiled in the report are BioMerieux, Hologic Inc., Becton Dickinson & Company, Cepheid Inc., Danaher Corporation, Affymetrix, Alere Inc., Abbott Laboratories, Bio-Rad Laboratories Inc., and DiaSorin.

KEY BENEFITS

  • The analysis helps in understanding the strategies adopted by various companies for gaining market share in the market for diagnostic testing of STDs 

  • The report provides comprehensive analysis of factors that drive and restrict the growth of the market for diagnostic testing of STDs. 

  • Market conditions of STD diagnostic testing market across all geographic regions are comprehensively analyzed. Key trends such as national and voluntary screening programs within regional markets, for example, European markets are expected to drive growth of the market.

  • Prime focus of the report is opportunity-analysis within this market. STD infected individuals refrain from testing in specialized STD clinics and Genito-Urinary Medicine (GUM) clinics due to the associated social stigma. Such change in the consumer buying behavior would prove to be an opportunity and be beneficial for public and private labs.

MARKET SEGMENTATION
The diagnostic testing of STDs market is segmented into types of STDs tested, testing devices, laboratory testing, PoC testing and geography.

MARKET BY SEXUALLY TRANSMITTED DISEASE TYPES

  • Chlamydia testing

  • Syphilis testing

  • Gonorrhoea testing

  • Herpes Simplex Virus testing

  • Human Papilloma Virus testing

  • Human Immunodeficiency Virus testing

  • Chancroid testing

MARKET BY LOCATION OF TESTING 

  • Laboratory Testing

    • Commercial/Private labs

    • Public Health Labs

  • Point of Care (PoC) testing

MARKET BY TESTING DEVICES

  • Laboratory Devices: Instruments and systems

    • Thermal Cyclers - PCR

    • Lateral Flow Readers - Immunochromatographic assays

    • Flow Cytometers

    • Differential Light Scattering machines

    • Absorbance microplate reader - Enzyme Linked Immunosorbent Assay (ELISA)

  • POC testing Devices: Various diagnostic kits

    • Phone chips (microfluidics + ICT)

    • Portable / bench top / rapid diagnostic kits

MARKET BY GEOGRAPHY

  • North America

  • Europe

  • Asia-Pacific

  • Latin America, Middle East, Africa (LAMEA)

TABLE OF CONTENTS

1 INTRODUCTION

1.1 Report Description
1.2 Reason for doing the study
1.3 Key Benefits
1.4 Key Market Segments
1.5 Key Audiences
1.6 Research Methodology

1.6.1 Secondary Research
1.6.2 Primary Research
1.6.3 Analyst tools and models

2 EXECUTIVE SUMMARY

2.1 CXO perspective
2.2 Market beyond what to expect by 2025 ($ Million)

2.2.1 Moderate growth scenario
2.2.2 Rapid growth scenario
2.2.3 Diminishing growth scenario

3 MARKET OVERVIEW

3.1 Market Definition and Scope
3.2 Upcoming trends for venereal diseases diagnostic testing market
3.3 Technological Advancements for venereal diseases diagnostic testing market
3.4 Emerging economies as a beneficial criterion for the investors 
3.5 Key Findings 

3.5.1 Top Factors Impacting for venereal diseases diagnostic testing market
3.5.2 Top Investment Pockets for venereal diseases diagnostic testing market
3.5.3 Top winning strategies for venereal diseases diagnostic testing market

3.6 Government Regulations and reimbursement
3.7 Value chain analysis
3.8 Market Share Analysis, 2013
3.9 Market Dynamics

3.9.1 Drivers
3.9.2 Restraints
3.9.3 Opportunities

4 GLOBAL VENEREAL DISEASES DIAGNOSTIC TESTING MARKET BY DISEASE TYPE

4.1 Chlamydia testing (volume and value)
4.2 P&S Syphilis testing (volume and value)
4.3 Gonorrhea testing (volume and value)
4.4 Herpes Simplex Virus (HSV) testing (volume and value)
4.5 Human Papilloma Virus (HPV) testing (volume and value)
4.6 Human Immunodeficiency Virus (HIV) testing (volume and value)
4.7 Chancroid testing (volume and value)

5 GLOBAL VENEREAL DISEASES DIAGNOSTIC TESTING MARKET BY LOCATION OF TESTING

5.1 Laboratory testing

5.1.1 Key market trends 
5.1.2 Key growth factors and opportunities 
5.1.3 Market size and forecast 
5.1.4 Commercial laboratory testing
5.1.5 Private laboratory testing
5.1.6 Public laboratory testing

5.2 POC testing

5.2.1 Key market trends 
5.2.2 Key growth factors and opportunities 
5.2.3 Market size and forecast

6 GLOBAL VENEREAL DISEASES DIAGNOSTIC TESTING MARKET BY TESTING DEVICES

6.1 Laboratory Testing Devices

6.1.1 PCRs
6.1.2 Immunochromatographic capillary flow dipstick technology (Assay)
6.1.3 Flow Cytometers
6.1.4 Differential Light Scattering
6.1.5 Enzyme Linked Immunosorbent Assay (ELISA)

6.2 POC Testing Devices

6.2.1 Phone chips (microfluidics + ICT)
6.2.2 Portable / bench top / rapid diagnostic kits

7 GLOBAL VENEREAL DISEASES DIAGNOSTIC TESTING MARKET BY GEOGRAPHY

7.1 North America

7.1.1 Key market trends 
7.1.2 Competitive scenario 
7.1.3 Key growth factors and opportunities 
7.1.4 Market size and forecast 

7.2 Europe

7.2.1 Key market trends 
7.2.2 Competitive scenario 
7.2.3 Key growth factors and opportunities 
7.2.4 Market size and forecast 

7.3 Asia-Pacific

7.3.1 Key market trends 
7.3.2 Competitive scenario 
7.3.3 Key growth factors and opportunities 
7.3.4 Market size and forecast 

7.4 LAMEA

7.4.1 Key market trends 
7.4.2 Competitive scenario 
7.4.3 Key growth factors and opportunities 
7.4.4 Market size and forecast 

8 COMPANY PROFILES

8.1 Roche Diagnostics

8.1.1 Overview 
8.1.2 Company snapshot 
8.1.3 Financial performance 
8.1.4 Strategic moves and developments 
8.1.5 SWOT analysis 

8.2 BioMerieux

8.2.1 Overview 
8.2.2 Company snapshot 
8.2.3 Financial performance 
8.2.4 Strategic moves and developments 
8.2.5 SWOT analysis 

8.3 Hologic, Inc.

8.3.1 Overview 
8.3.2 Company snapshot 
8.3.3 Financial performance 
8.3.4 Strategic moves and developments 
8.3.5 SWOT analysis 

8.4 Becton Dickinson & Company

8.4.1 Overview 
8.4.2 Company snapshot 
8.4.3 Financial performance 
8.4.4 Strategic moves and developments 
8.4.5 SWOT analysis 

8.5 Cepheid, Inc.

8.5.1 Overview 
8.5.2 Company snapshot 
8.5.3 Financial performance 
8.5.4 Strategic moves and developments 
8.5.5 SWOT analysis 

8.6 Danaher Corporation

8.6.1 Overview 
8.6.2 Company snapshot 
8.6.3 Financial performance 
8.6.4 Strategic moves and developments 
8.6.5 SWOT analysis 

8.7 Affymetrix, Inc.

8.7.1 Overview 
8.7.2 Company snapshot 
8.7.3 Financial performance 
8.7.4 Strategic moves and developments 
8.7.5 SWOT analysis 

8.8 Alere, Inc.

8.8.1 Overview 
8.8.2 Company snapshot 
8.8.3 Financial performance 
8.8.4 Strategic moves and developments 
8.8.5 SWOT analysis 

8.9 Abbott Laboratories

8.9.1 Overview 
8.9.2 Company snapshot 
8.9.3 Financial performance 
8.9.4 Strategic moves and developments 
8.9.5 SWOT analysis

8.10 DiaSorin

8.10.1 Overview 
8.10.2 Company snapshot 
8.10.3 Financial performance 
8.10.4 Strategic moves and developments 
8.10.5 SWOT analysis 

LIST OF TABLES

TABLE 1  GLOBAL VENEREAL DISEASES DIAGNOSTIC TESTING MODERATE GROWTH SCENARIO MARKET REVENUE BY GEOGRAPHY, 2020-2025 ($MILLION)
TABLE 2  GLOBAL VENEREAL DISEASES DIAGNOSTIC TESTING MODERATE GROWTH SCENARIO MARKET VOLUME BY GEOGRAPHY, 2020-2025 (MILLION TESTS)
TABLE 3  GLOBAL VENEREAL DISEASES DIAGNOSTIC TESTING RAPID GROWTH SCENARIO MARKET REVENUE BY GEOGRAPHY, 2020-2025 ($MILLION)
TABLE 4  GLOBAL VENEREAL DISEASES DIAGNOSTIC TESTING RAPID GROWTH SCENARIO MARKET VOLUME BY GEOGRAPHY, 2020-2025 (MILLION TESTS)
TABLE 5  GLOBAL VENEREAL DISEASES DIAGNOSTIC TESTING DIMINISHING GROWTH SCENARIO MARKET REVENUE BY GEOGRAPHY, 2020-2025 ($MILLION)
TABLE 6  GLOBAL VENEREAL DISEASES DIAGNOSTIC TESTING DIMINISHING GROWTH SCENARIO MARKET VOLUME BY GEOGRAPHY, 2020-2025 (MILLION TESTS)
TABLE 7  GLOBAL VENEREAL DISEASES DIAGNOSTIC TESTING MARKET,REVENUE BY TYPES, 2013-2020 ($ MILLION) 
TABLE 8  GLOBAL VENEREAL DISEASES DIAGNOSTIC TESTING MARKET, VOLUME BY TYPES, 2013-2020 (MILLION TESTS) 
TABLE 9  GLOBAL VENEREAL DISEASES DIAGNOSTIC TESTING MARKET REVENUE BY GEOGRAPHY, 2013-2020, ($ MILLION) 
TABLE 10  GLOBAL VENEREAL DISEASES DIAGNOSTIC TESTING MARKET VOLUME BY GEOGRAPHY, 2013-2020, (MILLION TESTS)
TABLE 11  GLOBAL CHLAMYDIA TESTING MARKET REVENUE BY GEOGRAPHY ($ MILLION) 
TABLE 12  GLOBAL CHLAMYDIA TESTING MARKET VOLUME BY GEOGRAPHY (MILLION TESTS) 
TABLE 13  GLOBAL P&S SYPHILIS TESTING MARKET REVENUE BY GEOGRAPHY ($ MILLION) 
TABLE 14  GLOBAL P&S SYPHILIS TESTING MARKET VOLUME BY GEOGRAPHY(MILLION TESTS) 
TABLE 15  GLOBAL GONORRHEA TESTING MARKET REVENUE BY GEOGRAPHY($ MILLION) 
TABLE 16  GLOBAL GONORRHEA TESTING MARKET VOLUME BY GEOGRAPHY(MILLION TESTS) 
TABLE 17  GLOBAL HERPES SIMPLEX VIRUS (HSV) TESTING MARKET REVENUE BY GEOGRAPHY ($ MILLION) 
TABLE 18  GLOBAL HERPES SIMPLEX VIRUS (HSV) TESTING MARKET VOLUME BY GEOGRAPHY (MILLION TESTS)
TABLE 19  GLOBAL HUMAN PAPILLOMA VIRUS (HPV) TESTING MARKET REVENUE BY GEOGRAPHY ($ MILLION)
TABLE 20  GLOBAL HUMAN PAPILLOMA VIRUS (HPV) TESTING MARKET VOLUME BY GEOGRAPHY(MILLION TESTS)
TABLE 21  GLOBAL HUMAN IMMUNODEFICIENCY VIRUS (HIV) TESTING MARKET REVENUE BY GEOGRAPHY ($ MILLION)
TABLE 22  GLOBAL HUMAN IMMUNODEFICIENCY VIRUS (HIV) TESTING MARKET VOLUME BY GEOGRAPHY(MILLION TESTS)
TABLE 23  GLOBAL CHANCROID TESTING MARKET REVENUE BY GEOGRAPHY($ MILLION)
TABLE 24  GLOBAL CHANCROID TESTING MARKET VOLUME BY GEOGRAPHY(MILLION TESTS)
TABLE 25  GLOBAL VENEREAL DISEASES DIAGNOSTIC TESTING MARKET REVENUE BY LOCATION OF TESTING DEVICES, 2013-2020, ($ MILLION)
TABLE 26  GLOBAL VENEREAL DISEASES DIAGNOSTIC TESTING MARKET REVENUE BY LOCATION OF TESTING, 2013-2020, ($ MILLION TESTS)
TABLE 27  NORTH AMERICA VENEREAL DISEASES DIAGNOSTIC TESTING MARKET REVENUE, BY TYPES, 2013-2020 ($ MILLION)
TABLE 28  NORTH AMERICA VENEREAL DISEASES DIAGNOSTIC TESTING MARKET VOLUME, BY TYPES, 2013-2020 (MILLION TESTS) 
TABLE 29  EUROPE VENEREAL DISEASES DIAGNOSTIC TESTING MARKET REVENUE, BY TYPES, 2013-2020 ($ MILLION TESTS)
TABLE 30  EUROPE VENEREAL DISEASES DIAGNOSTIC TESTING MARKET VOLUME, BY TYPES, 2013-2020 (MILLION TESTS)
TABLE 31  ASIA PACIFIC VENEREAL DISEASES DIAGNOSTIC TESTING MARKET REVENUE, BY TYPES, 2013-2020 ($ MILLION)
TABLE 32  ASIA PACIFIC VENEREAL DISEASES DIAGNOSTIC TESTING MARKET VOLUME, BY TYPES, 2013-2020 (MILLION TESTS)
TABLE 33  LAMEA VENEREAL DISEASES DIAGNOSTIC TESTING MARKET REVENUE, BY TYPES, 2013-2020 ($ MILLION)
TABLE 34  LAMEA VENEREAL DISEASES DIAGNOSTIC TESTING MARKET REVENUE, BY TYPES, 2013-2020 (MILLION TESTS)
TABLE 35  ROCHE DIAGNOSTICS BUSINESS SNAPSHOT
TABLE 36  BIOMERIEUX BUSINESS SNAPSHOT
TABLE 37  HOLOGIC, INC BUSINESS SNAPSHOT
TABLE 38  BECTON DICKINSON & COMPANY BUSINESS SNAPSHOT
TABLE 39  CEPHEID, INC.BUSINESS SNAPSHOT
TABLE 40  DANAHER CORPORATIONBUSINESS SNAPSHOT
TABLE 41  AFFYMETRIX, INC. BUSINESS SNAPSHOT
TABLE 42  ALERE, INC. BUSINESS SNAPSHOT
TABLE 43  ABBOTT LABORATORIES BUSINESS SNAPSHOT
TABLE 44  DIASORIN BUSINESS SNAPSHOT

LIST OF FIGURES

FIG. 1  IMPACT ANALYSIS OF MODERATE GROWTH SCENARIO (2020-2025)
FIG. 2  IMPACT ANALYSIS OF RAPID GROWTH SCENARIO (2020-2025)
FIG. 3  IMPACT ANALYSIS OF DIMINISHING GROWTH SCENARIO (2020-2025)
FIG. 4 TOP FACTORS IMPACTING GLOBAL VENEREAL DISEASES DIAGNOSTIC TESTING (2014-2020) TOP WINNING STRATEGIES IN GLOBAL VENEREAL DISEASES DIAGNOSTIC TESTING MARKET
FIG. 5  TOP INVESTMENT POCKETS OF GLOBAL VENEREAL DISEASES DIAGNOSTIC TESTING MARKET
FIG. 6  PORTER’S FIVE FORCE MODEL OF GLOBAL VENEREAL DISEASES DIAGNOSTIC TESTING MARKET
FIG. 7  VALUE CHAIN ANALYSIS OF GLOBAL VENEREAL DISEASES DIAGNOSTIC TESTING MARKET
FIG. 8  ROCHE DIAGNOSTICS SWOT ANALYSIS
FIG. 9  BIOMERIEUX SWOT ANALYSIS
FIG. 10  HOLOGIC, INC SWOT ANALYSIS
FIG. 11  BECTON DICKINSON & COMPANY SWOT ANALYSIS
FIG. 12  CEPHEID, INC.BUSINESS SWOT ANALYSIS
FIG. 13  DANAHER CORPORATION SWOT ANALYSIS
FIG. 14  AFFYMETRIX, INC. SWOT ANALYSIS
FIG. 15  ALERE, INC. SWOT ANALYSIS
FIG. 16  ABBOTT LABORATORIES SWOT ANALYSIS
FIG. 17  DIASORIN SWOT ANALSIS
FIG. 18  BUSINESS PERFORMANCE OF ROCHE DIAGNOSTICS
FIG. 19  BUSINESS PERFORMANCE OF BIOMERIEUX
FIG. 20  BUSINESS PERFORMANCE OF HOLOGIC, INC
FIG. 21  BUSINESS PERFORMANCE OF BECTON DICKINSON & COMPANY
FIG. 22  BUSINESS PERFORMANCE OF CEPHEID, INC.
FIG. 23  BUSINESS PERFORMANCE OF DANAHER CORPORATION
FIG. 24  BUSINESS PERFORMANCE OF AFFYMETRIX, INC.
FIG. 25  BUSINESS PERFORMANCE OF ALERE, INC
FIG. 26  BUSINESS PERFORMANCE OF ABBOTT LABORATORIES
FIG. 27  BUSINESS PERFORMANCE OF DIASORIN

...
Publisher Name : Allied Market Research

SIMILAR MARKET STUDIES

Please Select Format
Single User :- US $ 4740
Five User:- US $ 5910
Enterprise User:- US $ 8250
Data Pack :- US $ 3840

NEED MORE INFORMATION
Contact us
Call us +1-971-202-1575
--- or ---
help@bigmarketresearch.com
WHY BIG MARKET RESEARCH
With high quality and penned to perfection, Big Market Research is an exclusive online market to get best market research reports for your business needs and strategies. We recommend you to stop browsing as soon as you discover our website. This is because we firmly believe that once you reach here; all your business concerns will be addressed.

We have a huge collection of market research report from numerous filed which will provide you with all the necessary solution. We make sure that reports that we sell are true in context, have a quality that is unrivaled, fully integrated with equal spread of opinion. They will give you proper insights into different opportunities one may locate for their start-up pr expansion.

Let your qualms and concern be sidelined through our high end syndicated as well as customized reports.
Top